Dr. Marina Udier will join a live session at the 21st BioEquity Europe on Tuesday, May 18, 11:30 am CET.
The Next aCGT Europe Needs to Leapfrog — How? Follow the link below for more details. https://lnkd.in/dpAnmJZ
Nouscom receives approval to begin Phase 1b trials of NOUS-PEV, a novel personalized cancer immunotherapy
BASEL, Switzerland – 11th March 2021: Nouscom, a clinical stage immuno-oncology biotech developing next generation viral-vector based immunotherapies, today announces it has received approval [...]
Nouscom is presenting at the virtual Spring Private Company Showcase 2021 on March 11th
Find out more about the program and register here: Spring Private Company Showcase « Solebury Trout Access
Nouscom is presenting at the Biocapital Europe 2021 on March 11th
Find out more about the program and register here: https://www.biocapitaleurope.com/programme/
Nouscom appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer
BASEL, Switzerland – 11th December 2020: Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized genetic cancer vaccines, today announces that it has appointed [...]
Richard Davis | PHD
Rick joined Nouscom in September 2020 from Johnson and Johnson Innovation where he was the Global Oncology Venture and Transaction Lead. He was Chief Executive Officer of a European clinical [...]
Göran Ando | MD
Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment
Oncolytic viruses (OVs) are novel anti-tumor agents with the ability to selectively infect and kill tumor cells while sparing normal tissue. Beyond tumor cytolysis, OVs are capable of priming an [...]
New viral vectors for infectious diseases and cancer
ABSTRACT – Since the discovery in 1796 by Edward Jenner of vaccinia virus as a way to prevent and finally eradicate smallpox, the concept of using a virus to fight another virus has evolved [...]
Nouscom highlights cutting-edge science that led to the design of NOUS-209, a potential off-the-shelf neoantigen cancer vaccine for tumors with Microsatellite Instability
Article entitled ‘A genetic vaccine encoding shared cancer neoantigens to treat tumors with Microsatellite Instability’ published in Cancer Research BASEL, Switzerland – 22. July 2020: Nouscom, [...]
